- Home
- MDIA vs ZLAB Comparison
MDIA vs ZLAB Comparison
Compare MDIA & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDIA | ZLAB |
|---|---|---|
| Founded | 2019 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Broadcasting | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.0M | 2.0B |
| IPO Year | 2019 | 2017 |
Fundamental Metrics
Financial Performance| Metric | MDIA | ZLAB |
|---|---|---|
| Price | $0.98 | $19.12 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $49.60 |
| AVG Volume (30 Days) | 122.3K | ★ 954.4K |
| Earning Date | 05-19-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.46 |
| EPS | N/A | ★ N/A |
| Revenue | $133,336,000.00 | ★ $460,156,000.00 |
| Revenue This Year | N/A | $9.75 |
| Revenue Next Year | N/A | $26.03 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 39.52 | 15.33 |
| 52 Week Low | $0.54 | $15.96 |
| 52 Week High | $1.64 | $41.20 |
Technical Indicators
Market Signals| Indicator | MDIA | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 59.09 | 57.23 |
| Support Level | $0.59 | $16.78 |
| Resistance Level | $1.04 | $19.41 |
| Average True Range (ATR) | 0.08 | 0.69 |
| MACD | 0.02 | 0.22 |
| Stochastic Oscillator | 82.84 | 81.47 |
Price Performance
Historical ComparisonAbout MDIA Mediaco Holding Inc.
MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming, and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales, events including sponsorships and ticket sales, licensing, and syndication. The company has two business segments: the Audio segment and the Video segment. The company generates the majority of its revenue from the Audio segment.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.